Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002370754 | SCV002670140 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-11-15 | criteria provided, single submitter | clinical testing | The p.T2396S variant (also known as c.7186A>T), located in coding exon 48 of the ATM gene, results from an A to T substitution at nucleotide position 7186. The threonine at codon 2396 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003500739 | SCV004312172 | likely benign | Ataxia-telangiectasia syndrome | 2023-05-31 | criteria provided, single submitter | clinical testing |